Zurich, Switzerland (ots) - Sequana Medical is pleased to announce that it has received CE mark approval for use of its alfapump® system in patients with ascites caused by cancer (malignant ascites). The alfapump® system was first introduced to the European market last year for patients with refractory ascites ...
London (ots/PRNewswire) - FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole (ARIMIDEX(R)) tablets in hormonal therapy-naïve, postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer. ...
Takeda Pharmaceutical Company Limited and Dainippon Sumitomo Pharma Co., Ltd.
Osaka, Japan (ots/PRNewswire) - Dainippon Sumitomo Pharma Co., Ltd. ("DSP") (Headquarters: Osaka, Japan) and Takeda Pharmaceutical Company Limited ("Takeda") (Headquarters: Osaka, Japan) today announced that the European Medicines Agency (EMA) has confirmed the acceptance for review of the Marketing Authorization ...
Atlanta, Georgia (ots/PRNewswire) - Wellness Brand Will Fill Unmet Demand for Healthier Travel in New York City IHG (InterContinental Hotels Group) [LON: IHG; NYSE: IHG (ADRs)] today announces the signing of the first EVEN(TM) Hotels property which will be located in New York City, with ownership group CWC, Inc. The IHG-managed hotel will be located at 219 E 44th Street in the heart of midtown Manhattan, and will be a ...
Shire Pharmaceuticals Group Plc
Nyon, Switzerland (ots/PRNewswire) - Shire plc , today announced a long-term, broad based, multi-indication research collaboration in rare diseases with Fondazione Telethon, a major Italian biomedical charitable foundation, for research carried out at the Telethon Institute of Genetics and Medicine (TIGEM). This ...
Freienbach, Switzerland (ots) - EffRx Pharmaceuticals SA is proud to announce that BINOSTO (TM) (alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by prescription in the United States. The U.S. Food and Drug Administration earlier this year approved BINOSTO to treat ...
The International Osteoporosis Foundation (IOF)
Nyon, Switzerland (ots) - "A wrist fracture is a warning sign," says Professor John A. Kanis, president of the International Osteoporosis Foundation (IOF). "We urge all adults aged 50 and over who have suffered a wrist or other fragility fracture, to get tested for osteoporosis." Osteoporosis is a chronic 'silent' ...
Takeda Pharmaceutical Company Limited
Zurich (ots/PRNewswire) - ? Takeda Pharmaceuticals International GmbH ("Takeda") today announced that over one billion treatment courses of its gastrointestinal product pantoprazole have been administered around the world.[1] Initially launched in 1994 in Germany, pantoprazole, a proton pump inhibitor (PPI) used to ...
Astellas Pharma Europe Limited
Chertsey, England (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the granting of a marketing authorisation for BETMIGA[TM] (mirabegron) for the symptomatic treatment of urgency, increased micturition ...
Lyon, France (ots/PRNewswire) - Vaccine submitted to European Medicines Agency for licence review Sanofi Pasteur MSD plans to licence and commercialise an innovative 6-in-1 paediatric vaccine in its European territories. The new hexavalent vaccine, developed by Sanofi Pasteur, is the only fully liquid, ready to use ...
http://resources.euroadhoc.com/us/4S9vvMG1 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: ...
Bristol-Myers Squibb Foundation
Cape Town, South Africa (ots/PRNewswire) - Survey finds empowerment programme helps 57 percent of respondents reduce socioeconomic impact of HIV/AIDS by providing tools to reduce poverty and emotional burden of disease New research presented today at the first Africa Regional Conference on Gerontology and Geriatrics ...
Beerse, Belgium (ots/PRNewswire) - NOT INTENDED FOR US JOURNALISTS - OPTIMIZE study results to be presented in late-breaking poster presentation at the American Association for the Study of Liver Diseases (AASLD) 2012 show non-inferior sustained virological response (SVR12) rates in previously untreated genotype-1 ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - Proven biologic is first therapy available in both subcutaneous and intravenous formulations for adults with moderate to severe active rheumatoid arthritis Bristol-Myers Squibb announced today that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA(R) (abatacept), in combination with ...
London And Boston (ots/PRNewswire) - - EvaluateMedTech(TM) World Preview 2018 Reveals Medtech Sales Growth Rate Forecast to Outperform Global Prescription Drug Market Between 2011 and 2018 EvaluatePharma [http://www.evaluatepharma.com ](R) the premier source for life science sector analysis and consensus forecasts, today released its EvaluateMedTech(TM) World Preview 2018 [http://www.evaluatemedtech.com/MT2018 ] report at ...
Zutphen, The Netherlands (ots/PRNewswire) - Cryo-Save Group promotes the awareness of cord blood storage and stem cell therapies at several local educational events held throughout Europe. Cryo-Save continues its Cord Blood Awareness Months celebration by sponsoring educational events in the Netherlands, Italy and Spain during the months of October and November. It is ...
Vienna, Austria (ots/PRNewswire) - INTENDED FOR EUROPEAN MEDIA ONLY Results from a Phase I/II trial of the investigational compound lenvatinib (E7080), a multi-targeted, kinase inhibitor, in people with advanced hepatocellular cancer have been presented at the ESMO 2012 Congress (European Society for Medical ...
Bristol-Myers Squibb GmbH & Co. KGaA
Princeton, New Jersey (ots/PRNewswire) - - Long-Term Follow Up From Phase 3 Study (024) Demonstrated That 19.0 Percent of Treatment-Naïve Patients Who Received YERVOY at Investigational Dose of 10 mg/kg Plus Dacarbazine (DTIC) Were Alive at Four Years vs. 9.6 Percent of Patients Treated with DTIC Alone - Few New ...
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech [http://www.evaluatemedtech.com ](TM), a new intelligence service focused on the medical device and diagnostic sector. Powered by EvaluatePharma's proven platform ...
Roggwil, Switzerland (ots) - Colds and flu are the most frequent illnesses experienced by the Western world. They lead to tremendous costs to public health and the economy, being the leading cause of absences from work and school. This is especially the case during the autumn and winter months when almost everyone suffers colds or flu a few times. Immune resistance ...
Calgary, Alberta (ots/PRNewswire) - IVUS data will evaluate plaque regression in patients with Coronary Artery Disease TSX Exchange Symbol: RVX Resverlogix Corp. today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial targeting high-risk cardiovascular disease patients. ASSURE will evaluate the ability of RVX-208, Resverlogix's BET protein inhibitor, to regress atherosclerotic disease versus ...
Chicago (ots/PRNewswire) - The Myxo Etiologix model 5100, also known as the Myxo 5100 is a heart valve device manufactured and introduced to the market by Edwards LifeSciences (Irvine CA) in 2007. This device was specifically designed to treat the Myxo disease, an illness that causes a leaky heart valve. Despite being sold and surgically implanted into patients in the ...
Natick, Massachusetts (ots/PRNewswire) - Innovative Stent Solution to treat patients with Critical Limb Ischemia Boston Scientific has launched in European countries the PROMUS ELEMENT(TM) PLUS BTK (Below The Knee) Everolimus-Eluting Stent System for the treatment of certain severe peripheral artery lesions. The Drug Eluting Stent (DES) has CE Mark approval for both ...
Zutphen, The Netherlands (ots/PRNewswire) - Cryo-Save Group promotes the awareness of cord blood storage and stem cell therapies at several professional conferences held throughout eastern and southern Europe. It is with great pleasure that Cryo-Save supports the awareness, research and advancement of cord blood storage and therapies by taking part in and sponsoring ...
Lugano, Switzerland / Raleigh, N.C., USA (ots) - Gelclair® Strengthens DARA's Growing Portfolio of In-licensed Oncology and Oncology Supportive Care Products The Helsinn Group of Switzerland announced today that it has entered into an exclusive agreement with DARA BioSciences, Inc. (Nasdaq: DARA) for U.S. ...
http://resources.euroadhoc.com/us/xAaSwiA0 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open ...
Chicago (ots/PRNewswire) - Dr. Patrick McCarthy of Northwestern recently admitted under oath in a malpractice lawsuit that a patient he operated on in 2006 had a heart attack while receiving an investigational heart device called the Myxo 5100. This admission comes amid years of denials from McCarthy, the hospital ...
Manchester, England (ots/PRNewswire) - Investigational drug study follows earlier study with promising results in mild to moderate Alzheimer's patients TauRx Therapeutics today announced the initiation of a global Phase 3 clinical trial in a type of Frontotemporal Dementia (FTD) also known as Pick's Disease. The announcement, which immediately follows The 8th International Conference on Frontotemporal Dementias, held 5-7 ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus on cardiovascular disease and overall health, is pleased to announce that the company received a positive response to its lead product VASCAZEN(TM) at the European Society of ...
http://resources.euroadhoc.com/us/PH6rShim issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...